Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/15/2014US8779153 3-amino-pyrazole derivatives useful against tuberculosis
07/15/2014US8779151 Orally bioavailable caffeic acid related anticancer drugs
07/15/2014US8779149 Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators
07/15/2014US8779148 Fluoro-pyridinone derivatives useful as antibacterial agents
07/15/2014US8779146 Cilostazol cocrystals and compositions
07/15/2014US8779144 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
07/15/2014US8779142 Azabicyclo compound and salt thereof
07/15/2014US8779141 Viral inhibitors
07/15/2014US8779138 Camptothecin derivatives as chemoradiosensitizing agents
07/15/2014US8779132 Pharmaceutical compounds
07/15/2014US8779131 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
07/15/2014US8779129 Triazinedione derivatives as GABAB receptor modulators
07/15/2014US8779128 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
07/15/2014US8779127 Processes for preparing substituted pyrimidines
07/15/2014US8779126 Dye, photoelectric conversion element using the same, photoelectrochemical cell, and method of producing dye
07/15/2014US8779117 Pharmaceutical compositions comprising 5-azacytidine monohydrate
07/15/2014US8779099 MIF antagonists
07/15/2014US8779008 Polymeric micelles for drug delivery
07/15/2014US8779007 Preparation containing diol
07/15/2014US8779005 Salts of desvenlafaxine and a method of their preparation
07/15/2014US8779004 Stable emulsion formulations
07/15/2014US8779003 Method and composition for prolonging analgesic effect of local anesthetic
07/15/2014US8779002 Methods for treating a variety of diseases and conditions, and compounds useful therefor
07/15/2014US8779001 Stat3 inhibitors
07/15/2014US8779000 Saccharide free, storage stable thyroid hormone active drug formulations and methods for their production
07/15/2014US8778999 Non-steroidal anti-inflammatory ophthalmic compositions
07/15/2014US8778998 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
07/15/2014US8778997 Antiviral treatments
07/15/2014US8778996 Method of treating a human being for a class of neurological defects and seizure disorders
07/15/2014US8778995 Use of hydroxyoleic acid and related compounds in the manufacture of drugs
07/15/2014US8778994 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting
07/15/2014US8778993 Method of using β-hydroxy-β-methylbutyrate for the treatment of disease conditions
07/15/2014US8778992 Method of using beta-hydroxy-beta-methylbutyrate to treat allergies and asthma
07/15/2014US8778991 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
07/15/2014US8778990 Betulinic acid derivatives and methods of use thereof
07/15/2014US8778989 Cosmetic composition comprising a lipid fraction from vegetable source and anticrystaling agent
07/15/2014US8778988 Endoperoxides and methods of photocatalytically synthesizing endoperoxides
07/15/2014US8778987 Use of 4-hydroxychalcone derivatives for masking an unpleasant taste
07/15/2014US8778986 Treatment of glycogen synthase kinase-based disease
07/15/2014US8778985 Inhibiting amyloid-beta peptide/rage interaction at the blood-brain barrier
07/15/2014US8778983 Polycyclic compounds as lysophosphatidic acid receptor antagonists
07/15/2014US8778982 Synergistic microbicidal compositions
07/15/2014US8778981 Methods and compositions for locally increasing body fat
07/15/2014US8778980 Heterocyclic aspartyl protease inhibitors
07/15/2014US8778979 Glutamate agents in the treatment of mental disorders
07/15/2014US8778978 Hydroxybenzoate salts of metanicotine compounds
07/15/2014US8778977 Pyridinonyl PDK1 inhibitors
07/15/2014US8778976 Compositions and methods for the treatment of metabolic disorders
07/15/2014US8778975 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
07/15/2014US8778974 Trisubstituted 1,2,4 triazoles
07/15/2014US8778973 Alkene oxindole derivatives
07/15/2014US8778972 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1
07/15/2014US8778971 Medicinal treatment of dermal diseases in companion animals
07/15/2014US8778970 Benzyl piperidine compound
07/15/2014US8778969 Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines
07/15/2014US8778968 Male contraceptive
07/15/2014US8778967 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/15/2014US8778966 Quinolinone derivatives as PARP and tank inhibitors
07/15/2014US8778965 Lotion preparation containing pyridonecarboxylic acid derivative
07/15/2014US8778964 Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
07/15/2014US8778963 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
07/15/2014US8778962 Treatment of solid tumors with rapamycin derivatives
07/15/2014US8778961 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
07/15/2014US8778960 Methods for treating antipsychotic-induced weight gain
07/15/2014US8778959 AZA-bridged ring-fused indoles and indolines
07/15/2014US8778958 Synthesis of metabolically stable agents for alcohol and drug abuse
07/15/2014US8778957 CGRP receptor antagonists
07/15/2014US8778956 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
07/15/2014US8778955 Indole derivatives or benzimidazole derivatives for modulating IkB kinase
07/15/2014US8778954 Phenylpyridine derivative and medicinal agent comprising same
07/15/2014US8778953 Inhibitors of P38 map kinase
07/15/2014US8778952 Method of reducing intraosseous hypertension
07/15/2014US8778951 Heteroaryl compounds and their uses
07/15/2014US8778950 Cannabinoid receptor modulators
07/15/2014US8778949 1-(2-phenoxymethylphenyl)piperazine compounds
07/15/2014US8778948 Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof
07/15/2014US8778947 Methods of administering pirfenidone therapy
07/15/2014US8778946 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds
07/15/2014US8778945 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
07/15/2014US8778944 Pyridazinone compounds
07/15/2014US8778943 Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-α]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamides
07/15/2014US8778942 Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitors
07/15/2014US8778940 Chemical inducers of neurogenesis
07/15/2014US8778939 Compounds
07/15/2014US8778938 Hepatitis C virus inhibitors
07/15/2014US8778937 Benzimidazole boronic acid derivatives as PI3 kinase inhibitors
07/15/2014US8778936 Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
07/15/2014US8778935 Imidazopyrazines for use as kinase inhibitors
07/15/2014US8778934 Heterocyclic compound and use thereof
07/15/2014US8778933 Diazepinedione derivative
07/15/2014US8778932 Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them
07/15/2014US8778931 Substituted hydroxamic acids and uses thereof
07/15/2014US8778930 Process for the resolution of enantiomers of (3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and application in the synthesis of ivabradine
07/15/2014US8778929 Substituted heteroaryl inhibitors of B-RAF
07/15/2014US8778928 Indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use
07/15/2014US8778927 Smoothened antagonism for the treatment of hedgehog pathway-related disorders
07/15/2014US8778926 Compounds, pharmaceutical compositions and uses thereof
07/15/2014US8778925 Pyridine and pyrimidine based compounds as Wnt signaling pathway inhibitors for the treatment of cancer
07/15/2014US8778924 Modified release amoxicillin products
07/15/2014US8778923 GLP-1 receptor modulators